Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase
about
Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complexGBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKAPhosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitorsMechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersCalcium Sensitization Mechanisms in Gastrointestinal Smooth MusclesEndogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling.Role of serine-threonine phosphoprotein phosphatases in smooth muscle contractilityMyosin light chain kinase activation and calcium sensitization in smooth muscle in vivoIntegrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylationSPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1).Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.Identification and characterization of a novel integrin-linked kinase inhibitorThy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation.Maturation and long-term hypoxia-induced acclimatization responses in PKC-mediated signaling pathways in ovine cerebral arterial contractility.ILK mediates the effects of strain on intestinal epithelial wound closureLow-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.MAPKs represent novel therapeutic targets for gastrointestinal motility disorders.Regulation of the uterine contractile apparatus and cytoskeleton.Regulation of myosin light chain phosphatase and pulmonary arterial relaxation.Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone developmentUsing Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo ModelThe regulation of smooth muscle contractility by zipper-interacting protein kinase.Role of various kinases in muscarinic M3 receptor-mediated contraction of longitudinal muscle of rat colon.G(q)-dependent signalling by the lysophosphatidic acid receptor LPA(3) in gastric smooth muscle: reciprocal regulation of MYPT1 phosphorylation by Rho kinase and cAMP-independent PKASmooth muscle signalling pathways in health and disease.Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemiaQLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatmenIntegrin linked kinase (ILK) expression and function in vascular smooth muscle cellsMaturation and the role of PKC-mediated contractility in ovine cerebral arteries.Regulation of smooth muscle contraction by small GTPases.Magnesium lithospermate B, an active extract of Salvia miltiorrhiza, mediates sGC/cGMP/PKG translocation in experimental vasospasm.Integrin-linked kinase: not so 'pseudo' after all.Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle.Transcriptional regulatory events initiated by Ascl1 and Neurog2 during neuronal differentiation of P19 embryonic carcinoma cells.Opportunities to Target Specific Contractile Abnormalities with Smooth Muscle Protein Kinase Inhibitors.Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction.MYPT1 isoforms expressed in HEK293T cells are differentially phosphorylated after GTPγS treatment.Epigenetic regulation of integrin-linked kinase expression depending on adhesion of gastric carcinoma cells.
P2860
Q24298111-61F097CC-3B68-4D4A-9263-0843A0F46162Q24530581-7353E77B-ED28-4666-AD60-BC3B43D5019AQ24562656-76AE9FC1-4A7A-4E57-8184-D3B65C30A1FDQ24644388-45B36B48-0610-40F4-B86A-D12AAE59C5C6Q26753129-0788E1D5-CFB8-4FCE-BDE7-F688724AD07CQ26772115-DA3C7F2E-AE84-4E02-BC8A-002E1510D504Q26849244-62EDE100-B0F4-44E3-9D2D-7CF473CB91DCQ27693957-57AA9679-D257-42F2-807F-ACCAAE1EAD2AQ28507897-7D3398BA-85DA-482F-92FC-C623AA918FD3Q28749480-E3FF1DE9-2EF6-4614-AE5F-44116A0921A3Q33222107-8BB57CEC-F561-4514-95C4-45CAAC4F3FC1Q33719596-1E7ECEAD-AEAB-46AA-A4D2-C43D0DAC8E0FQ33835741-5A339F8C-21EB-4B3D-A319-C7903C701CDFQ33985104-AB340AB6-E314-4DFC-8FF2-9D8892EAE573Q33991101-F487246C-B693-4B1F-8ACF-E4468C8FF3F5Q34305827-5EEA3B08-8243-4649-8476-694384017397Q34597585-CEE6E644-DBEE-4507-A606-913BA11866FBQ34992347-1BA8F8D6-F303-4B5B-9A0B-8AB01AA126C6Q34992382-8065BB8E-1E3D-454E-A332-FA7A3BF1842FQ36026689-6BA96EEF-9C05-4AE5-96D7-86A482E767C2Q36333429-844C26FD-5F3F-4748-8184-44F09B5F8AC1Q36528098-82A023D9-B3C4-4FDB-8FA1-7AE624B93B5CQ36720975-F283364F-68A5-4E5C-A3E2-E711F9755658Q36814756-7A875D3B-87FF-45B0-B40C-8A14492A024FQ36887060-6C3B9F80-7EF0-4A48-9FF0-95F48049463EQ36915971-5685B4E6-0C2F-4191-B6F4-65A5798C4C90Q37217197-079A7D57-4359-4E88-92DF-053DC975A9EFQ37242557-497A9AAD-6EAD-4AC2-836D-841A87EDC50CQ37277114-32D5AEB2-31FD-46D5-9AE1-40B5C5E21D19Q37406751-F622511E-4887-4778-83D2-B4D6406FD8D1Q37474858-2AD8D4A0-D9BE-4F0F-B357-9E0BA1D727D1Q37649264-7A616E90-66D7-480F-9CBB-43153E57BABCQ37718838-DC38A60D-AEEE-4262-863E-8998671997D9Q37878251-6A43F1BB-D6EC-4069-BC53-600B0B054905Q38743234-C7BBF480-5F89-4C49-BBE3-6A3459964B4CQ38959782-C7BE0A7D-D3A4-4D09-8B76-5EF947541C76Q38974336-E8DFE6FF-9ECE-4961-8C06-588102D25DD2Q39162238-DA9EC65A-D8B9-4763-B9F3-F668024A34ADQ39304331-77A7FF54-EC25-4E6C-A0BF-D9FB39DEB022Q40229398-67B071E6-8839-450C-A84B-AE72FC08155F
P2860
Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase
description
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/10/15)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/10/15)
@nl
наукова стаття, опублікована в жовтні 2002
@uk
مقالة علمية (نشرت في 15-10-2002)
@ar
name
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@ast
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@en
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@nl
type
label
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@ast
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@en
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@nl
prefLabel
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@ast
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@en
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@nl
P2093
P2860
P3181
P356
P1433
P1476
Phosphorylation of the myosin ...... I-1, by integrin-linked kinase
@en
P2093
Cindy Sutherland
David L. Brautigan
Jing Ti Deng
Michael P. Walsh
P2860
P304
P3181
P356
10.1042/BJ20020522
P407
P50
P577
2002-10-15T00:00:00Z